Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Invitrx Therapeutics Inc.
FDA Inspection
•Invitrx Therapeutics Inc.•March 22, 2022

Invitrx Therapeutics Inc. – FDA Inspection, Mar 22, 2022

Record Details

This FDA Inspection record concerns Invitrx Therapeutics Inc., with an inspection on March 22, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Invitrx Therapeutics Inc.
Inspection Date
March 22, 2022
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
View Company Profile

ID · 6d1c02ea-ed52-43f5-be1c-143b4644fade

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1165854
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies

FDA Citations

18
  1. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  2. 21 CFR 211.188Prepared for each batch, include complete information
  3. 21 CFR 211.188(b)(3)Identification of each component or in-process material
  4. 21 CFR 211.167(a)Sterility/pyrogen-free testing
  5. 21 CFR 211.84(a)Components withheld from use pending release
  6. 21 CFR 211.110(b)In-process materials specifications testing
  7. 21 CFR 211.101(b)Identification of new containers
  8. 21 CFR 1271.265(c)(2)Improperly released for distribution
  9. 21 CFR 211.160(b)Scientifically sound laboratory controls
  10. 21 CFR 1271.180(a)Procedures to meet core CTGP

Showing 10 of 18 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Invitrx Therapeutics Inc.

3
DateClassificationOfficeProject area
April 30, 2025Not classifiedLos Angeles District OfficeHuman Cellular, Tissue, and Gene Therapies
September 13, 2019VAICenter for Food Safety and Applied NutritionColors and Cosmetics Technology
April 3, 2019OAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
Other documents for Invitrx Therapeutics Inc.
  • FDA Inspection 1265382 - 2025-04-30
  • FDA Inspection 1101970 - 2019-09-13
  • FDA Inspection 1084910 - 2019-04-03

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Invitrx Therapeutics Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.